Empagliflozin and linagliptin and Zostavax Subcutaneous
Determining the interaction of Empagliflozin and linagliptin and Zostavax Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
Generic Name: zoster vaccine live
Brand name: Zostavax
Synonyms: Zostavax
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and linagliptin-Zoster Vaccine (Live/Attenuated)
- Empagliflozin and linagliptin-Zoster Vaccine (Recombinant)
- Empagliflozin and linagliptin-Zoster vaccine inactivated
- Empagliflozin and linagliptin-Zoster vaccine live
- Empagliflozin and linagliptin-Zoster vaccine recombinant, adjuvanted Intramuscular
- Empagliflozin and linagliptin-Zoster vaccine, live Subcutaneous
- Zostavax Subcutaneous-Empagliflozin and metformin
- Zostavax Subcutaneous-Empagliflozin and Metformin Extended-Release Tablets
- Zostavax Subcutaneous-Empagliflozin and Metformin Tablets
- Zostavax Subcutaneous-Empliciti
- Zostavax Subcutaneous-Emsam
- Zostavax Subcutaneous-Emsam Transdermal